52-Week Performance Chart

Powered by FactSet Research Systems Inc

Corporate Actions/Books Closed

Recent Dividends & Distributions

More
US RECORD DATE US PAYABLE DATE NET DR AMOUNT
May 09, 2025 May 29, 2025 0.5270
May 10, 2024 May 30, 2024 0.4944
May 09, 2023 May 30, 2023 0.2044
May 23, 2022 May 25, 2022 0.0000

Institutional Ownership

TOP INSTITUTIONAL HOLDERS POSITION
TOP MUTUAL FUND HOLDERS POSITION

Data provided by FactSet Research Systems Inc.

Important Notice to Investors of Unsponsored DRs and GDNs:

From time to time, BNY may pay a rebate to brokers that deposit shares with BNY for the issuance of unsponsored depositary receipts (DRs) or global depositary notes. BNY assumes no obligation or responsibility, and expressly disclaims any liability arising out of, or relating to, such rebates, including without limitation whether the rebate or any portion of it is passed on to the beneficial holders by the brokers.
Unsponsored DRs may be issued by multiple depositary banks servicing a particular DR program. Consequently, as a result of Depository Trust & Clearing Corporation (“DTCC”) practice, the actual cash distribution fees charged may differ from the BNY fees detailed in the fee schedule as fees will be charged in accordance with the fee schedule of the depositary bank that is considered to be the “First Filer”. The fees to be charged for any particular unsponsored cash distribution will be disclosed on the event announcement published by the “First Filer”. BNY takes no responsibility for the level of fees charged by any other depositary bank. The “First Filer” is the depositary bank that filed the first Form F-6 for a program with the U.S. Securities and Exchange Commission (“SEC”). In the event the actual “First Filer” does not have DRs outstanding for a program, the next depositary bank who filed a
Form F-6 with the SEC and has DRs outstanding will be deemed to be the First Filer for these purposes.

DR Details

DR Symbol BIOGY
CUSIP 09072J102
DR Venue OTC
DR ISIN US09072J1025
Ratio DR:ORD 1:1
First Filer BK
Underlying ISIN SE0017769995
Underlying SEDOL BPX36K2
Country Sweden
Effective Date Apr 03, 2013
Depositary BK, CIT, DB (Unsponsored)
Industry HealthCareEquip.&Ser
BioGaia AB develops, markets and sells probiotic products. The products are primarily based on various strains of the lactic acid bacterium Lactobacillus reuteri in combination with packaging solutions to develop probiotic products with a long shelf life. The Company's products include: ProTectis, which is used for the indication of digestive health, children and adults, and for prevention and treatment of colic, regurgitation, constipation, diarrhea; ProDentis, which is used for the indication of adults oral health, periodontal disease and gingivitis; and Gastrus, which is used for the indication of adults digestive health, and side effects from treatment of Helicobacter pylori infection.

Data provided by Mergent, Inc.

Fee Type in US Dollar per ADS Deposit Agreement
Annual Depositary Service up to $0.1000
Cancellation up to $0.1000
Cash Distribution up to $0.1000
Issuance up to $0.1000
Registrar Inspection up to $0.0000
Cash Distribution(Other) up to $0.1000
Rights - Issuance up to $0.1000
Stock Dividend up to $0.1000
Transfer up to $0.0000
Cable Fee per Cancellation $17.5000

Monthly Trading Summary

More
Month Month End DR Close Price DR Trading Volume Avg Day DR Trading Volume
Apr.25 10.63 50,377 12,594
Mar.25 10.96 1,251 417
Feb.25 11.60 501 251

Powered by FactSet Research Systems Inc.

This information and data is provided for general informational purposes only.  Certain displayed prices may not reflect direct quotes from any market or exchange, but may instead reflect an approximation of price based on a methodology that includes a calculation that includes the price of underlying securities and foreign exchange rate selected for such purpose. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to Terms of Use

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE